Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 485-490

  Dobrian, Anca D ^a   Lieb, David C ^a   Ma, Qian ^a   Lindsay, John W ^a   Cole, Banumathi K ^a   Ma, Kaiwen ^a   Chakrabarti, Swarup K ^a   Kuhn, Norine S ^a   Wohlgemuth, Stephen D ^b   Fontana, Mark ^b   Nadler, Jerry L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Metabolic and Weight Loss Surgery Center   (United States)

Author keywords

12 15 Lipoxygenases; Adipose tissue; Cytokines; Human; Inflammation; Obesity; Vasculature

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15A LIPOXYGENASE; ARACHIDONATE 15B LIPOXYGENASE; CD34 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CYTOKINES; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OBESITY;

ANIMALIA;

EID: 78650173914     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.065     Document Type: Article

References (31)

1. O'Rourke R.W., Metcalf M.D., White A.E., Madala A., Winters B.R., Maizlin, Jobe B.A., Roberts C.T., Slifka M.K., Marks D.L. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. 2009, 33:978-990.
2. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
3. Sam S., Haffner S., Davidson M.H., Agostino R.B.D'., Feinstein S., Kondos G., Perez A., Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 2009, 32:932-937.
4. A.D. Dobrian, D.C. Lieb, B.K. Cole, D.A. Taylor-Fishwick, S.K. Chakrabarti, and J.L. Nadler, Functional and pathological roles of the 12- and 15-lipoxygenases, Prog. Lipid Res. in press.
5. Law I.K., Xu A., Lam K.S., Berger T., Mak T.W., Vanhoutte P.M., Liu J.T., Sweeney G., Zhou M., Yang B., Wang Y. Lipocalin-2 deficiency attenuates insulin resistance associated with ageing and obesity. Diabetes 2010, 59:872-882.
6. Nunemaker C.S., Chen M., Pei H., Kimble S.D., Keller S.R., Carter J.D., Yang Z., Smith K.M., Wu R., Bevard M.H., Garmey J.C., Nadler J.L. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1065-E1075.
7. Poeckel D., Zemski Berry K.A., Murphy R.C., Funk C.D. Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice. J. Biol. Chem. 2009, 284:21077-21089.
8. Sears D.D., Miles P.D., Chapman J., Ofrecio J.M., Almazan F., Thapar D., Miller Y.I. 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS ONE 2009, 4:e7250.
9. Chakrabarti S.K., Cole B.K., Wen Y., Keller S.R., Nadler J.L. 12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes. Obesity (Silver Spring) 2009.
10. Kim J.A., Gu J.L., Natarajan R., Berliner J.A., Nadler J.L. A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 1995, 15:942-948.
11. Wen Y., Gu J., Chakrabarti S.K., Aylor K., Marshall J., Takahashi Y., Yoshimoto T., Nadler J.L. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology 2007, 148:1313-1322.
12. Wen Y., Gu J., Vandenhoff G.E., Liu X., Nadler J.L. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1933-1938.
13. Brash A.R., Boeglin W.E., Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. USA 1997, 94:6148-6152.
14. Nadel J.A., Conrad D.J., Ueki I.F., Schuster A., Sigal E. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. J. Clin. Invest. 1991, 87:1139-1145.
15. Conrad D.J., Kuhn H., Mulkins M., Highland E., Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 1992, 89:217-221.
16. Nassar G.M., Morrow J.D., Roberts L.J., Lakkis F.G., Badr K.F. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 1994, 269:27631-27634.
17. Rydberg E.K., Krettek A., Ullstrom C., Ekstrom K., Svensson P.A., Carlsson L.M., Jonsson-Rylander A.C., Hansson G.I., McPheat W., Wiklund O., Ohlsson B.G., Hulten L.M. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2040-2045.
18. Danielsson K.N., Rydberg E.K., Ingelsten M., Akyurek L.M., Jirholt P., Ullstrom C., Forsberg G.B., Boren J., Wiklund O., Hulten L.M. 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. Atherosclerosis 2008, 199:34-40.
19. Fairfax B.P., Vannberg F.O., Radhakrishnan J., Hakonarson H., Keating B.J., Hill A.V., Knight J.C. An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6. Hum. Mol. Genet. 2010, 19:720-730.
20. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 1998, 83:847-850.
21. Dobrian A.D., Schriver S.D., Khraibi A.A., Prewitt R.L. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004, 43:48-56.
22. Ma K., Nunemaker C.S., Wu R., Chakrabarti S.K., Taylor-Fishwick D.A., Nadler J.L. 12-Lipoxygenase products reduce insulin secretion and {beta}-cell viability in human islets. J. Clin. Endocrinol. Metab. 2010, 95:887-893.
23. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., Bouloumie A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
24. Kuhn H., Chaitidis P., Roffeis J., Walther M. Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling. J. Cardiovasc. Pharmacol. 2007, 50:609-620.
25. Viita H., Markkanen J., Eriksson E., Nurminen M., Kinnunen K., Babu M., Heikura T., Turpeinen S., Laidinen S., Takalo T., Yla-Herttuala S. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ. Res. 2008, 102:177-184.
26. Schneider M., Wortmann M., Mandal P.K., Arpornchayanon W., Jannasch K., Alves F., Strieth S., Conrad M., Beck H. Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity. Neoplasia 2010, 12:254-263.
27. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., Rood J.C., Burk D.H., Smith S.R. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
28. Madsen L., Petersen R.K., Sorensen M.B., Jorgensen C., Hallenborg P., Pridal L., Fleckner J., Amri E.Z., Krieg P., Furstenberger G., Berge R.K., Kristiansen K. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 2003, 375:539-549.
29. Hallenborg P., Jorgensen C., Petersen R.K., Feddersen S., Araujo P., Markt P., Langer T., Furstenberger G., Krieg P., Koppen A., Kalkhoven E., Madsen L., Kristiansen K. Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity. Mol. Cell. Biol. 2010, 30:4077-4091.
30. Hulten L.M., Olson F.J., Aberg H., Carlsson J., Karlstrom L., Boren J., Fagerberg B., Wiklund O. 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha. Eur. J. Clin. Invest. 2009.
31. Lee M.J., Wu Y., Fried S.K. Adipose tissue remodeling in pathophysiology of obesity. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:371-376.